Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

1.

Impact of hip fracture on hospital care costs: a population-based study.

Leal J, Gray AM, Prieto-Alhambra D, Arden NK, Cooper C, Javaid MK, Judge A; REFReSH study group.

Osteoporos Int. 2015 Aug 19. [Epub ahead of print]

PMID:
26286626
2.

Can the publication of guidelines change the management of early rheumatoid arthritis? An interrupted time series analysis from the United Kingdom.

Judge A, Wallace G, Prieto-Alhambra D, Arden NK, Edwards CJ.

Rheumatology (Oxford). 2015 Aug 4. pii: kev268. [Epub ahead of print]

PMID:
26242858
3.

Early (1-year) Discontinuation of Different Anti-osteoporosis Medications Compared: A Population-Based Cohort Study.

Carbonell-Abella C, Pages-Castella A, Javaid MK, Nogues X, Farmer AJ, Cooper C, Diez-Perez A, Prieto-Alhambra D.

Calcif Tissue Int. 2015 Jul 23. [Epub ahead of print]

PMID:
26202819
4.

Incidence and Predictors of Multiple Fractures Despite High Adherence to Oral Bisphosphonates: A Binational Population-Based Cohort Study.

Hawley S, Javaid MK, Rubin KH, Judge A, Arden NK, Vestergaard P, Eastell R, Diez-Perez A, Cooper C, Abrahamsen B, Prieto-Alhambra D.

J Bone Miner Res. 2015 Jul 14. doi: 10.1002/jbmr.2595. [Epub ahead of print]

PMID:
26174968
5.

CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss.

Rodríguez-Sanz M, García-Giralt N, Prieto-Alhambra D, Servitja S, Balcells S, Pecorelli R, Díez-Pérez A, Grinberg D, Tusquets I, Nogués X.

J Mol Endocrinol. 2015 Aug;55(1):69-79. doi: 10.1530/JME-15-0079. Epub 2015 Jun 24.

PMID:
26108486
6.

Risks and Benefits of Bisphosphonate Therapies.

Reyes C, Hitz M, Prieto-Alhambra D, Abrahamsen B.

J Cell Biochem. 2015 Jun 20. doi: 10.1002/jcb.25266. [Epub ahead of print]

PMID:
26096687
7.

Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis.

Driessen JH, Henry RM, van Onzenoort HA, Lalmohamed A, Burden AM, Prieto-Alhambra D, Neef C, Leufkens HG, de Vries F.

Calcif Tissue Int. 2015 Aug;97(2):104-12. doi: 10.1007/s00223-015-9993-5. Epub 2015 Apr 17.

8.

Socio-economic status and the risk of developing hand, hip or knee osteoarthritis: a region-wide ecological study.

Reyes C, Garcia-Gil M, Elorza JM, Mendez-Boo L, Hermosilla E, Javaid MK, Cooper C, Diez-Perez A, Arden NK, Bolibar B, Ramos R, Prieto-Alhambra D.

Osteoarthritis Cartilage. 2015 Aug;23(8):1323-9. doi: 10.1016/j.joca.2015.03.020. Epub 2015 Mar 26.

PMID:
25819582
9.

Bone Tissue Properties Measurement by Reference Point Indentation in Glucocorticoid-Induced Osteoporosis.

Mellibovsky L, Prieto-Alhambra D, Mellibovsky F, Güerri-Fernández R, Nogués X, Randall C, Hansma PK, Díez-Perez A.

J Bone Miner Res. 2015 Sep;30(9):1651-6. doi: 10.1002/jbmr.2497. Epub 2015 Jun 11.

PMID:
25736591
10.

Future projections of total hip and knee arthroplasty in the UK: results from the UK Clinical Practice Research Datalink.

Culliford D, Maskell J, Judge A, Cooper C, Prieto-Alhambra D, Arden NK; COASt Study Group.

Osteoarthritis Cartilage. 2015 Apr;23(4):594-600. doi: 10.1016/j.joca.2014.12.022. Epub 2015 Jan 9.

PMID:
25579802
11.

Increased hip fracture and mortality in chronic kidney disease individuals: the importance of competing risks.

Pérez-Sáez MJ, Prieto-Alhambra D, Barrios C, Crespo M, Redondo D, Nogués X, Díez-Pérez A, Pascual J.

Bone. 2015 Apr;73:154-9. doi: 10.1016/j.bone.2014.12.020. Epub 2014 Dec 27.

PMID:
25549867
12.

Socioeconomic status and its association with the risk of developing hip fractures: a region-wide ecological study.

Reyes C, García-Gil M, Elorza JM, Fina-Avilés F, Mendez-Boo L, Hermosilla E, Coma E, Carbonell C, Medina-Peralta M, Ramos R, Bolibar B, Díez-Pérez A, Prieto-Alhambra D.

Bone. 2015 Apr;73:127-31. doi: 10.1016/j.bone.2014.12.019. Epub 2014 Dec 24.

PMID:
25542156
13.

Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study.

Martinez-Laguna D, Tebe C, Javaid MK, Nogues X, Arden NK, Cooper C, Diez-Perez A, Prieto-Alhambra D.

Osteoporos Int. 2015 Feb;26(2):827-33. doi: 10.1007/s00198-014-2986-9. Epub 2014 Dec 9.

PMID:
25488807
14.

The descriptive epidemiology of rheumatoid arthritis in Catalonia: a retrospective study using routinely collected data.

Fina-Aviles F, Medina-Peralta M, Mendez-Boo L, Hermosilla E, Elorza JM, Garcia-Gil M, Ramos R, Bolibar B, Javaid MK, Edwards CJ, Cooper C, Arden NK, Prieto-Alhambra D.

Clin Rheumatol. 2014 Oct 26. [Epub ahead of print]

PMID:
25344777
15.

Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a nationwide case-control study.

Prieto-Alhambra D, Muñoz-Ortego J, De Vries F, Vosse D, Arden NK, Bowness P, Cooper C, Diez-Perez A, Vestergaard P.

Osteoporos Int. 2015 Jan;26(1):85-91. doi: 10.1007/s00198-014-2939-3. Epub 2014 Oct 24.

PMID:
25341971
16.

Drug utilization in patients with OA: a population-based study.

Wilson N, Sanchez-Riera L, Morros R, Diez-Perez A, Javaid MK, Cooper C, Arden NK, Prieto-Alhambra D.

Rheumatology (Oxford). 2015 May;54(5):860-7. doi: 10.1093/rheumatology/keu403. Epub 2014 Oct 21.

PMID:
25339639
17.

Linking of primary care records to census data to study the association between socioeconomic status and cancer incidence in Southern Europe: a nation-wide ecological study.

Garcia-Gil M, Elorza JM, Banque M, Comas-Cufí M, Blanch J, Ramos R, Méndez-Boo L, Hermosilla E, Bolibar B, Prieto-Alhambra D.

PLoS One. 2014 Oct 20;9(10):e109706. doi: 10.1371/journal.pone.0109706. eCollection 2014.

18.

HIV infection, bone metabolism, and fractures.

Güerri-Fernández R, Villar-García J, Díez-Pérez A, Prieto-Alhambra D.

Arq Bras Endocrinol Metabol. 2014 Jul;58(5):478-83. Review.

19.

Oral bisphosphonate use and total knee/hip implant survival: validation of results in an external population-based cohort.

Prieto-Alhambra D, Lalmohamed A, Abrahamsen B, Arden NK, de Boer A, Vestergaard P, de Vries F.

Arthritis Rheumatol. 2014 Nov;66(11):3233-40. doi: 10.1002/art.38789.

PMID:
25047677
20.

Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial.

Concepción-Martín M, Gómez-Oliva C, Juanes A, Díez X, Prieto-Alhambra D, Torras X, Sainz S, Villanueva C, Farre A, Guarner-Argente C, Guarner C.

Endoscopy. 2014 Oct;46(10):851-6. doi: 10.1055/s-0034-1377306. Epub 2014 Jun 30.

PMID:
24977398
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk